Rockefeller Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Rockefeller Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.59K	Buy	2,732 +2,184	+399%	+$8.95K	﹤0.01%	4009
2025 Q4	$1.85K	Sell	548 -114	-17%	-$296	﹤0.01%	4343
2025 Q3	$867	Buy	+662	New	+$685	﹤0.01%	4208
2023 Q1	–	Sell	-99	Closed	-$1K	–	2933
2022 Q4	$1K	Hold	99	–	–	﹤0.01%	3699
2022 Q3	$1K	Buy	+99	New	+$1.12K	﹤0.01%	3732
2021 Q4	–	Sell	-128	Closed	-$1K	–	3876
2021 Q3	$1K	Buy	+128	New	+$1.65K	﹤0.01%	3580
2020 Q4	–	Sell	-155	Closed	-$1K	–	2934
2020 Q3	$1K	Sell	155 -105	-40%	-$1.04K	﹤0.01%	2490
2020 Q2	$3K	Sell	260 -3,007	-92%	-$30.8K	﹤0.01%	2232
2020 Q1	$33K	Buy	3,267 +589	+22%	+$6.92K	﹤0.01%	1363
2019 Q4	$36K	Hold	2,678	–	–	﹤0.01%	1233
2019 Q3	$23K	Hold	2,678	–	–	﹤0.01%	1178
2019 Q2	$29K	Sell	2,678 -520	-16%	-$5.83K	﹤0.01%	933
2019 Q1	$36K	Hold	3,198	–	–	﹤0.01%	1016
2018 Q4	$28K	Hold	3,198	–	–	﹤0.01%	585
2018 Q3	$49K	Hold	3,198	–	–	﹤0.01%	438
2018 Q2	$51K	Hold	3,198	–	–	﹤0.01%	444
2018 Q1	$41K	Buy	+3,198	New	+$39.9K	﹤0.01%	423

Other funds holding IRWD

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Rockefeller Capital Management's IRWD Position: Q1 2026 in Review

Rockefeller Capital Management increased its Ironwood Pharmaceuticals (IRWD) stake by 399% in Q1 2026, buying an estimated $8.95K and bringing the position to 2,732 shares worth $9.59K. The position accounts for ﹤0.01% of the portfolio, ranked #4009.

Rockefeller Capital Management first reported a position in IRWD in Q1 2018 and has held it in 17 quarters since. The position peaked at $51K in Q2 2018. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

Rockefeller Capital Management held 2,732 shares of Ironwood Pharmaceuticals worth $9.59K as of Q1 2026.
Rockefeller Capital Management bought 2,184 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $8.95K.
Ironwood Pharmaceuticals made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #4009 holding.
Rockefeller Capital Management first reported a position in Ironwood Pharmaceuticals in Q1 2018 and has held it in 17 quarters since.
Rockefeller Capital Management's Ironwood Pharmaceuticals position peaked at $51K in Q2 2018.
226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.